Avoro Capital Advisors LLC Increases Position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

Avoro Capital Advisors LLC boosted its position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 9.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,111,111 shares of the biopharmaceutical company’s stock after purchasing an additional 100,000 shares during the period. […]

Related Keywords

Canada ,Amyw Schulman , ,Elo Mutual Pension Insurance Co ,Royal Bank ,Wells Fargo Company ,Alnylam Pharmaceuticals ,Securities Exchange Commission ,Regal Investment Advisors ,Alnylam Pharmaceuticals Trading ,Nasdaq ,Exchange Commission ,Avoro Capital Advisors ,Wolfe Research ,Quilter Plc ,Humankind Investments ,Alnylam Pharmaceuticals Profile ,Quarter For Alnylam Pharmaceuticals ,Alnylam Pharmaceuticals Inc ,News Ratings For Alnylam Pharmaceuticals Daily ,Free Report ,Capital Advisors ,Investment Advisors ,Seven Eight Capital ,Get Free Report ,Director Amy ,Visit Holdingschannel ,Alnylam Pharmaceuticals Daily ,